AKT1 and viral infectious disease: The top 10 kinase targets that have drugs “under active development” status for viral infections is protein kinase C (PKC), AXL receptor tyrosine kinase (AXL), Casein kinase II (CK2), mitogen-activated protein kinase (MAPK), mitogen-activated protein kinase kinase (MAP2K; MAPKK; MEK), extracellular signal-regulated kinase (ERK), MAPK p38, cyclin-dependent kinase (CDK) 1 (CDK1), TEK receptor tyrosine kinase, and protein kinase B (PKB; Akt).